New Search
To Refine Your Search Change your search text Below
148 results found for: pharma
On December 12, 2014, the central government released the Uniform Code for Pharmaceuticals Marketing Practices to be voluntarily complied by pharma industries with respect to marketing practices. It was mentioned in the code that if the code is not implemented […]
Good Manufacturing Practices (GMP) in Pharmaceutical Sector: On December 28, 2023, the Ministry of Health and Family Welfare, Government of India, revised the Drugs Rules, 1945, under Gazette Notification Number G.S.R. 922(E), introducing updated Good Manufacturing Practices (GMP) and requirements […]
Dr A Ramkishan – Deputy Drugs Controller of Central Drugs Standard Control Organization (CDSCO) said that Indian pharmacy regulatory body is undergoing tremendous change in emphasizing quality. Speaking at APTICON 2016, the 21st National Convention of the Association of Pharmacy Teachers […]
The Pharmacovigilance Programme of India (PvPI) and Central Drugs Standard Control Organisation (CDSCO) will be drafting this guidance document for good pharmacovigilance (PV) in India for drug safety. The main intention behind this guideline is to give the industry with […]
The Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare is planning to prepare a good pharmacovigilance practices guidance document for the industry. The objective of this document is to provide the industry with best practices in drug study and helping them […]
Register muted export revenue and stable domestic revenue in India to be expected to increase in the next budgetary year. 5 per cent of overall pharmaceutical exports and 8-10 per cent on domestic pharma is expected. Speaking about the exports, current PM Narendra […]
Drugs in India are regulated by the CDSCO and the NPPA. The CDSCO monitors clinical trials, regulatory approvals, import / export and quality control for pharmaceutical products, whilst the NPAA is involved in the price regulation for pharmaceuticals in the […]
The Competition Commission of India (CCI) is planning to execute a study on pharmaceutical and healthcare sectors in the NCR region due to the concerns over the speculations of unfair ways of competition. The study would cover pharma companies, its […]
The government of India plans to set up a venture capital fund worth 500 cr to boost the domestic pharma industry and also encourage establishing / upgrading domestic manufacturing facilities by providing loans cheaper. READ ALSO: The Indian Healthcare Market Overview. […]